A glimpse of the pathogenetic mechanisms of Wnt/β-catenin signaling in diabetic nephropathy

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Xiao, Li ^a   Wang, Ming ^a   Yang, Shikun ^a   Liu, Fuyou ^a   Sun, Lin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CALVASCULIN; CELL SURFACE RECEPTOR; DESMIN; GLUCOSE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; VITAMIN D RECEPTOR; WNT PROTEIN;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL DAMAGE; CELL DEATH; CELL DIFFERENTIATION; CELL MOTILITY; DIABETIC NEPHROPATHY; END STAGE RENAL DISEASE; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLOMERULAR FILTRATION BARRIER; GLUCOSE BLOOD LEVEL; HUMAN; KIDNEY FIBROSIS; KIDNEY POLYCYSTIC DISEASE; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MESANGIUM CELL; NEGATIVE FEEDBACK; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PODOCYTE; PROTEIN EXPRESSION; UPREGULATION; WNT SIGNALING PATHWAY; GENETICS; KIDNEY; METABOLISM; PATHOLOGY; REVIEW;

BETA CATENIN; DIABETIC NEPHROPATHIES; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; KIDNEY; MESANGIAL CELLS; WNT SIGNALING PATHWAY;

EID: 84896126899     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/987064     Document Type: Article

References (53)

1. Packham D. K., Alves T. P., Dwyer J. P., Atkins R., De Zeeuw D., Cooper M., Shahinfar S., Lewis J. B., Lambers Heerspink H. J., Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database. The American Journal of Kidney Diseases 2012 59 1 75 83 2-s2.0-83655201254 10.1053/j.ajkd.2011.09.017
2. Hovind P., Rossing P., Tarnow L., Smidt U. M., Parving H.-H., Progression of diabetic nephropathy. Kidney International 2001 59 2 702 709 2-s2.0-0035134101 10.1046/j.1523-1755.2001.059002702.x (Pubitemid 32157935)
3. Parving H.-H., Harrington J. T., Lewis J., Boner G., Viberti G. C., Gilbert R., Raz I., Cooper M., Rossing K., Diabetic nephropathy: prevention and treatment. Kidney International 2001 60 5 2041 2055 2-s2.0-0034773498 10.1046/j.1523-1755.2001.00020.x (Pubitemid 33000016)
4. Sun Y. M., Su Y., Li J., Wang L. F., Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy. Biochemical and Biophysical Research Communications 2013 433 359 361
5. Kanwar Y. S., Wada J., Sun L., Xie P., Wallner E. I., Chen S., Chugh S., Danesh F. R., Diabetic nephropathy: mechanisms of renal disease progression. Experimental Biology and Medicine 2008 233 1 4 11 2-s2.0-37549035027 10.3181/0705-MR-134
6. Ban C. R., Twigg S. M., Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers. Vascular Health and Risk Management 2008 4 3 575 596 2-s2.0-47849127561 (Pubitemid 352037917)
7. Brosius F. C. III, Khoury C. C., Buller C. L., Chen S., Abnormalities in signaling pathways in diabetic nephropathy. Expert Review of Endocrinology and Metabolism 2010 5 1 51 64 2-s2.0-77949831941 10.1586/eem.09.70
8. Lin C.-L., Wang J.-Y., Huang Y.-T., Kuo Y.-H., Surendran K., Wang F.-S., Wnt/ β -catenin signaling modulates survival of high glucose-stressed mesangial cells. Journal of the American Society of Nephrology 2006 17 10 2812 2820 2-s2.0-33749251120 10.1681/ASN.2005121355 (Pubitemid 44484671)
9. Dai C., Stolz D. B., Kiss L. P., Monga S. P., Holzman L. B., Liu Y., Wnt/ β -catenin signaling promotes podocyte dysfunction and albuminuria. Journal of the American Society of Nephrology 2009 20 9 1997 2008 2-s2.0-69849089270 10.1681/ASN.2009010019
10. Zhou T., He X., Cheng R., Zhang B., Zhang R. R., Chen Y., Takahashi Y., Murray A. R., Lee K., Gao G., Ma J.-X., Implication of dysregulation of the canonical wingless-type MMTV integration site (WNT) pathway in diabetic nephropathy. Diabetologia 2012 55 1 255 266 2-s2.0-84856711650 10.1007/s00125-011-2314-2
11. Hwang I., Seo E.-Y., Ha H., Wnt/ β -catenin signaling: a novel target for therapeutic intervention of fibrotic kidney disease. Archives of Pharmacal Research 2009 32 12 1653 1662 2-s2.0-77249149901 10.1007/s12272-009- 2200-3
12. Schinner S., Willenberg H. S., Schott M., Scherbaum W. A., Pathophysiological aspects of Wnt-signaling in endocrine disease. European Journal of Endocrinology 2009 160 5 731 737 2-s2.0-65549166298 10.1530/EJE-08-0831
13. Glinka A., Wu W., Delius H., Monaghan A. P., Blumenstock C., Niehrs C., Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 1998 391 6665 357 362 2-s2.0-0032556910 10.1038/34848 (Pubitemid 28093502)
14. Rattner A., Hsieh J.-C., Smallwood P. M., Gilbert D. J., Copeland N. G., Jenkins N. A., Nathans J., A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. Proceedings of the National Academy of Sciences of the United States of America 1997 94 7 2859 2863 2-s2.0-0030905162 10.1073/pnas.94.7.2859 (Pubitemid 27157229)
15. Chiang Y. T., Ip W., Jin T., The role of the Wnt signaling pathway in incretin hormone production and function. Frontiers in Physiology 2012 3, article 273
16. Königshoff M., Eickelberg O., WNT signaling in lung disease: a failure or a regeneration signal? The American Journal of Respiratory Cell and Molecular Biology 2010 42 1 21 31 2-s2.0-73949090577 10.1165/rcmb.2008-0485TR
17. Clevers H., Wnt/ β -catenin signaling in development and disease. Cell 2006 127 3 469 480 2-s2.0-33746808398 10.1016/j.cell.2006.10.018 (Pubitemid 44647433)
18. Pinto D., Clevers H., Wnt control of stem cells and differentiation in the intestinal epithelium. Experimental Cell Research 2005 306 2 357 363 2-s2.0-19544375032 10.1016/j.yexcr.2005.02.022 (Pubitemid 40732761)
19. Fodde R., Brabletz T., Wnt/ β -catenin signaling in cancer stemness and malignant behavior. Current Opinion in Cell Biology 2007 19 2 150 158 2-s2.0-33847740988 10.1016/j.ceb.2007.02.007 (Pubitemid 46386404)
20. Chilosi M., Poletti V., Zamò A., Lestani M., Montagna L., Piccoli P., Pedron S., Bertaso M., Scarpa A., Murer B., Cancellier A., Maestro R., Semenzato G., Doglioni C., Aberrant Wnt/ β -catenin pathway activation in idiopathic pulmonary fibrosis. The American Journal of Pathology 2003 162 5 1495 1502 2-s2.0-0242500879 (Pubitemid 36512831)
21. Wei J., Melichian D., Komura K., Hinchcliff M., Lam A. P., Lafyatis R., Gottardi C. J., MacDougald O. A., Varga J., Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma? Arthritis and Rheumatism 2011 63 6 1707 1717 2-s2.0-79958036406 10.1002/art.30312
22. Surendran K., McCaul S. P., Simon T. C., A role for Wnt-4 in renal fibrosis. The American Journal of Physiology 2002 282 3 F431 F441 2-s2.0-0036084033 (Pubitemid 34654531)
23. He W., Dai C., Li Y., Zeng G., Monga S. P., Liu Y., Wnt/ β -catenin signaling promotes renal interstitial fibrosis. Journal of the American Society of Nephrology 2009 20 4 765 776 2-s2.0-65249134946 10.1681/ASN.2008060566
24. Kawakami T., Ren S., Duffield J. S., Wnt signalling in kidney diseases: dual roles in renal injury and repair. Journal of Pathology 2013 229 221 231
25. Lin C.-L., Cheng H., Tung C.-W., Huang W.-J., Chang P.-J., Yang J.-T., Wang J.-Y., Simvastatin reverses high glucose-induced apoptosis of mesangial cells via modulation of Wnt signaling pathway. The American Journal of Nephrology 2008 28 2 290 297 2-s2.0-38349045501 10.1159/000111142
26. Zhu D., Yu H., He H., Ding J., Tang J., Cao D., Hao L., Spironolactone inhibits apoptosis in rat mesangial cells under hyperglycaemic conditions via the Wnt signalling pathway. Molecular and Cellular Biochemistry 2013 380 185 193
27. Mishra R., Emancipator S. N., Kern T., Simonson M. S., High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells. Kidney International 2005 67 1 82 93 2-s2.0-10944263493 10.1111/j.1523-1755.2005.00058. x (Pubitemid 40019229)
28. Lin C.-L., Wang J.-Y., Ko J.-Y., Surendran K., Huang Y.-T., Kuo Y.-H., Wang F.-S., Superoxide destabilization of β -catenin augments apoptosis of high-glucose-stressed mesangial cells. Endocrinology 2008 149 6 2934 2942 2-s2.0-44249108994 10.1210/en.2007-1372 (Pubitemid 351724526)
29. Mu J., Pang Q., Guo Y. H., Chen J. G., Zeng W., Huang Y. J., Functional implications of microRNA-215 in TGF-beta1-induced phenotypic transition of mesangial cells by targeting CTNNBIP1. PLoS ONE 2013 8 e58622
30. Ho C., Lee P. H., Hsu Y. C., Wang F. S., Huang Y. T., Lin C. L., Sustained Wnt/beta-catenin signaling rescues high glucose induction of transforming growth factor-beta1-mediated renal fibrosis. The American Journal of the Medical Sciences 2012 344 374 382
31. Kato H., Gruenwald A., Suh J. H., Miner J. H., Barisoni-Thomas L., Taketo M. M., Faul C., Millar S. E., Holzman L. B., Susztak K., Wnt/ β -catenin pathway in podocytes integrates cell adhesion, differentiation, and survival. Journal of Biological Chemistry 2011 286 29 26003 26015 2-s2.0-79960425136 10.1074/jbc.M111.223164
32. Rooney B., O'Donovan H., Gaffney A., Browne M., Faherty N., Curran S. P., Sadlier D., Godson C., Brazil D. P., Crean J., CTGF/CCN2 activates canonical Wnt signalling in mesangial cells through LRP6: implications for the pathogenesis of diabetic nephropathy. FEBS Letters 2011 585 3 531 538 2-s2.0-79551483244 10.1016/j.febslet.2011.01.004
33. Liu Y., New insights into epithelial-mesenchymal transition in kidney fibrosis. Journal of the American Society of Nephrology 2010 21 2 212 222 2-s2.0-77949351029 10.1681/ASN.2008121226
34. He W., Kang Y. S., Dai C., Liu Y., Blockade of Wnt/ β -catenin signaling by paricalcitol ameliorates proteinuria and kidney injury. Journal of the American Society of Nephrology 2011 22 1 90 103 2-s2.0-78651384347 10.1681/ASN.2009121236
35. Li Z., Xu J., Xu P., Liu S., Yang Z., Wnt/beta-catenin signalling pathway mediates high glucose induced cell injury through activation of TRPC6 in podocytes. Cell Proliferation 2013 46 76 85
36. Jiang L., Xu L., Song Y., Li J., Mao J., Zhao A. Z., He W., Yang J., Dai C., Calmodulin-dependent protein kinase II/cAMP response element-binding protein/Wnt/beta-catenin signaling cascade regulates angiotensin II-induced podocyte injury and albuminuria. Journal of Biological Chemistry 2013 288 23368 23379
37. Li Y., Kang Y. S., Dai C., Kiss L. P., Wen X., Liu Y., Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. The American Journal of Pathology 2008 172 2 299 308 2-s2.0-39549098861 10.2353/ajpath.2008.070057 (Pubitemid 351282018)
38. Yamaguchi Y., Iwano M., Suzuki D., Nakatani K., Kimura K., Harada K., Kubo A., Akai Y., Toyoda M., Kanauchi M., Neilson E. G., Saito Y., Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy. The American Journal of Kidney Diseases 2009 54 4 653 664 2-s2.0-70349263307 10.1053/j.ajkd.2009.05.009
39. Kretzler M., Teixeira V. P., Unschuld P. G., Cohen C. D., Wanke R., Edenhofer I., Mundel P., Schlöndorff D., Holthöfer H., Integrin-linked kinase as a candidate downstream effector in proteinuria. The FASEB Journal 2001 15 10 1843 1845 2-s2.0-0035432903
40. Lv Z., Hu M., Zhen J., Lin J., Wang Q., Wang R., Rac1/PAK1 signaling promotes epithelial-mesenchymal transition of podocytes in vitro via triggering beta-catenin transcriptional activity under high glucose conditions. International Journal of Biochemistry and Cell Biology 2013 45 255 264
41. Vallon V., The proximal tubule in the pathophysiology of the diabetic kidney. The American Journal of Physiology 2011 300 5 R1009 R1022 2-s2.0-79955771730 10.1152/ajpregu.00809.2010
42. Ho J. H., Yun J. L., Su H. P., Jang H. L., Taub M., High glucose-induced oxidative stress inhibits Na+/glucose cotransporter activity in renal proximal tubule cells. The American Journal of Physiology 2005 288 5 F988 F996 2-s2.0-17644397486 10.1152/ajprenal.00327.2004 (Pubitemid 40569765)
43. Li M.-X., Liu B.-C., Epithelial to mesenchymal transition in the progression of tubulointerstitial fibrosis. Chinese Medical Journal 2007 120 21 1925 1930 2-s2.0-36148979331 (Pubitemid 350111068)
44. Lee Y. J., Han H. J., Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3 β Snail1, and β -catenin in renal proximal tubule cells. The American Journal of Physiology 2010 298 5 F1263 F1275 2-s2.0-77951528072 10.1152/ajprenal.00475.2009
45. Hills C. E., Siamantouras E., Smith S. W., Cockwell P., Liu K.-K., Squires P. E., TGF β modulates cell-to-cell communication in early epithelial-to-mesenchymal transition. Diabetologia 2012 55 3 812 824 2-s2.0-84856744679 10.1007/s00125-011-2409-9
46. Tian X., Zhang J., Tan T. K., Lyons J. G., Zhao H., Niu B., Lee S. R., Association of beta-catenin with P-Smad3 but not LEF-1 dissociates in vitro profibrotic from anti-inflammatory effects of TGF-beta1. Journal of Cell Science 2013 126 67 76
47. Huang B. Y., Cao L. Y., Fu X. G., Effects of tanshinone IIA on Wnt/beta-catenin signaling pathway of high glucose induced renal tubular epithelial cell transdifferentiation. Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo ZhongXiYi JieHe ZaZhi 2012 32 965 969
48. Surendran K., Schiavi S., Hruska K. A., Wnt-dependent β -catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis. Journal of the American Society of Nephrology 2005 16 8 2373 2384 2-s2.0-28444468088 10.1681/ASN.2004110949 (Pubitemid 41725055)
49. Benzing T., Simons M., Walz G., Wnt signaling in polycystic kidney disease. Journal of the American Society of Nephrology 2007 18 5 1389 1398 2-s2.0-34248187071 10.1681/ASN.2006121355 (Pubitemid 46717505)
50. Ziyadeh F. N., The extracellular matrix in diabetic nephropathy. The American Journal of Kidney Diseases 1993 22 5 736 744 2-s2.0-0027452124 (Pubitemid 23330946)
51. Park I.-S., Kiyomoto H., Abboud S. L., Abboud H. E., Expression of transforming growth factor- β and type IV collagen in early streptozotocin-induced diabetes. Diabetes 1997 46 473 480 2-s2.0-0030992062 (Pubitemid 27090278)
52. Lin C.-L., Wang J.-Y., Ko J.-Y., Huang Y.-T., Kuo Y.-H., Wang F.-S., Dickkopf-1 promotes hyperglycemia-induced accumulation of mesangial matrix and renal dysfunction. Journal of the American Society of Nephrology 2010 21 1 124 135 2-s2.0-75149137022 10.1681/ASN.2008101059
53. Akhmetshina A., Palumbo K., Dees C., Bergmann C., Venalis P., Zerr P., Horn A., Kireva T., Beyer C., Zwerina J., Schneider H., Sadowski A., Riener M.-O., MacDougald O. A., Distler O., Schett G., Distler J. H. W., Activation of canonical Wnt signalling is required for TGF- β -mediated fibrosis. Nature Communications 2012 3, article 1734 2-s2.0-84859179083 10.1038/ncomms1734